Lambl's excrescence in transcatheter aortic valve implantation: prevalence and risk of embolic events

Cammalleri, Valeria; Idone, Gaetano; Cosma, Joseph; Marino, Maria M; Mauceri, A; Stifano, Giuseppe; Muscoli, Saverio; Boffi, Federica; Persis, Francesca DE; Vico, Pasquale De; Versaci, Francesco; Luozzo, Marco Di; Romeo, Francesco

doi:10.23736/s2724-5683.20.05482-1

Cited by 3 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, the TAX approach is not considered an alternative to the TF approach, but is the second most effective and safest choice. The imaging rule is crucial for determining anatomical suitability, device selection, and choosing the optimal access site to avoid common complications such as peripheral vascular lesions and anemia [ 18 , 19 ].…”

Section: Discussionmentioning

confidence: 99%

The Transaxillary Route as a Second Access Option in TAVI Procedures: Experience of a Single Centre

Muscoli

Cammalleri

Bonanni

et al. 2022

IJERPH

Self Cite

View full text Add to dashboard Cite

Background: The aim of our study was to determine the feasibility and efficacy of transaxillary (TAX) TAVI in patients not eligible for the transfemoral route. Methods: This is a retrospective study of a single center. We analysed 262 patients treated with TAVI. In 17 patients (6.5%), the procedure was performed with the TAX approach. Procedural and hospital data, 30-day safety, and clinical efficacy were assessed and compared between the transfemoral and TAX groups. Results: In the TAX groups, we found a higher prevalence of men (p = 0.001), smokers (p = 0.033), and previous strokes (p = 0.02). The EUROSCORE II was higher in the TAX group (p = 0.014). The success rate of the device was 100%. TAX was associated with a longer procedure time (p = 0.001) and shorter median device time (p = 0.034) in minutes. Patients treated with TAX had a longer hospital stay (p = 0.005) and higher overall bleeding rate (p = 0.001). Peripheral neurological complications were more frequent with TAX (p = 0.001), which almost completely resolved by 30 days. Conclusions: TAX TAVI is safe and effective and should be considered as a second choice when transfemoral TAVI is not feasible due to severe comorbidities.

show abstract

Section: Discussionmentioning

confidence: 99%